Rite Aid Corp

Five types of opioid-related shareholder resolutions are currently on ballots.

Morningstar medalist managers picked up these names during the fourth quarter of 2016.

If investors can get past valuations in the consumer staples sector, there are a raft of low-cost ETF options offering access to the space.

Beaten down by the specter of rising interest rates, a sluggish emerging-markets consumer, and currency headwinds, the U.S. consumer staples sector offers strong dividends, high-quality stocks, and an attractive relative valuation.

Both Walgreen and Express Scripts stand to lose if their dispute isn't resolved.

Three tricks and three treats for Halloween.

Credit spreads for nonfinancial issuers (especially those in defensive sectors) held up better last week than financials, which widened significantly versus the rest of the market.

The flow of drugs and money along the pharma supply chain can be complicated.

We analyze the trends affecting retail drugstores, distributors, and PBMs.

The fundamentals don't support the meteoric rise in these stock prices over the last year.

Pharma wholesalers are insulated from both the economy and health-care reform.

This wide-moat firm appears to be exceptionally cheap today.

Plus, Tribune eyes a breakup, FedEx delivers strong quarter, and more.

Plus, Research in Motion stays on track, Barr notches win on Plan B, and more.

Fed lowers overnight interest rates to lowest level since 1962.

Despite encouraging results, investors should hold off for now.

Which stocks are hot, and which are not.

Debt-laden firm's bottom line may continue to hemorrhage.